Evidence map›Paper›PMID 42845221›Full record

ReviewAllergy, asthma & immunology research2026

Advances in the Diagnosis and Management of Allergic Bronchopulmonary Aspergillosis/Mycosis.

Koichiro Asano, Naoki Okada, Jun Tanaka, Katsuyoshi Tomomatsu, Yoshiki Shiraishi, Tsuyoshi Oguma

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Allergy, asthma & immunology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Koichiro AsanoThe Institute of Medical Sciences, Tokai University, Isehara, Japan.ORCID https://orcid.org/0000-0002-9044-3061
Naoki OkadaDivision of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Isehara, Japan.
Jun TanakaDivision of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Isehara, Japan.
Katsuyoshi TomomatsuDivision of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Isehara, Japan.
Yoshiki ShiraishiDivision of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Isehara, Japan.
Tsuyoshi OgumaDivision of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Isehara, Japan.

Funding

Japan Agency for Medical Research and Development 19ek0410055Japan Agency for Medical Research and Development 22ek0410097Japan Agency for Medical Research and Development 25ek0410138Japan Society for the Promotion of Science 24K02490
6 · The paper itself

Abstract

Allergic bronchopulmonary aspergillosis/mycosis (ABPA/ABPM) is an immunologically mediated pulmonary disorder triggered by the colonization of filamentous fungi in the airways of patients with asthma or cystic fibrosis, leading to type I and III hypersensitivity responses, eosinophilic mucus plug formation, and central bronchiectasis. Over the past decade, advances in basic and clinical research have substantially reshaped the understanding and management of this disease. Although

Indexed as

allergic bronchopulmonary aspergillosis (ABPA)Aspergillus fumigatusasthmaBiologic agentsbronchiectasisextracellular trap cell deathmucus plugSchizophyllum commune

Identifiers

PMID42845221
PMCPMC13655405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.